WHO. Listings of WHO’s response to COVID-19 2020. https://www.who.int/news/item/29-06-2020-covidtimeline.
WHO. WHO coronavirus (COVID-19) dashboard. https://covid19.who.int
Behnoush AH, Ahmadi N, Mozafar M, Mirghaderi SP, Azad AJ, Houjaghan AK, et al. Anxiety, depression, and their contributing factors among nurses infected with COVID-19 in Iran: a cross-sectional study. Iranian Red Crescent Med J. 2022;24(2).
Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York city: a prospective cohort study. Lancet. 2020;395(10239):1763–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bandyopadhyay S, Baticulon RE, Kadhum M, Alser M, Ojuka DK, Badereddin Y, et al. Infection and mortality of healthcare workers worldwide from COVID-19: a systematic review. BMJ Global Health. 2020;5(12):e003097.
Article
PubMed
Google Scholar
Shali M, Behnoush AH, Shabani EA, Khazaeipour Z. Individual and working experiences of healthcare workers infected with COVID-19 A qualitative study. Japan J Nursing Sci. 2022;19(2):12465.
Article
Google Scholar
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet 2018 392(10159):1789–858.
Schimmel J, Manini AF. Opioid use disorder and COVID-19: biological plausibility for worsened outcomes. Subst Use Misuse. 2020;55(11):1900–1.
Article
PubMed
PubMed Central
Google Scholar
Mansuri Z, Shah B, Trivedi C, Beg U, Patel H, Jolly T. Opioid use disorder treatment and potential interactions with novel COVID-19 medications: a clinical perspective. Primary Care Companion CNS Dis. 2020;22(4):27062.
Google Scholar
Alexander GC, Stoller KB, Haffajee RL, Saloner B. An epidemic in the midst of a pandemic: opioid use disorder and COVID-19. Ann Intern Med. 2020;173(1):57–8.
Article
PubMed
Google Scholar
Becker WC, Fiellin DA. When epidemics collide: coronavirus disease 2019 (COVID-19) and the opioid crisis. Ann Intern Med. 2020;173(1):59–60.
Article
PubMed
Google Scholar
Qeadan F, Mensah NA, Tingey B, Bern R, Rees T, Madden EF, et al. The association between opioids, environmental, demographic, and socioeconomic indicators and COVID-19 mortality rates in the United States: an ecological study at the county level. Archiv Public Health. 2021;79(1):101.
Article
Google Scholar
Fond G, Pauly V, Leone M, Llorca PM, Orleans V, Loundou A, et al. Disparities in intensive care unit admission and mortality among patients with Schizophrenia and COVID-19: a national cohort study. Schizophr Bull. 2021;47(3):624–34.
Article
PubMed
Google Scholar
Jeon HL, Kwon JS, Park SH, Shin JY. Association of mental disorders with SARS-CoV-2 infection and severe health outcomes: nationwide cohort study. Br J psychiatry J Mental Sci. 2021;218(6):344–51.
Article
Google Scholar
Wei Y, Shah R. Substance use disorder in the COVID-19 pandemic a systematic review of vulnerabilities and complications. Pharmaceuticals. 2020;13(7):155.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kumar N, Janmohamed K, Nyhan K, Martins SS, Cerda M, Hasin D, et al. Substance use and substance use disorder, in relation to COVID-19: protocol for a scoping review. Syst Rev. 2021;10(1):48.
Article
PubMed
PubMed Central
Google Scholar
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339: b2535.
Article
PubMed
PubMed Central
Google Scholar
GA Wells BS, D O'Connell, J Peterson, V Welch, M Losos, P Tugwell. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.
Article
PubMed
PubMed Central
Google Scholar
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101.
Article
CAS
PubMed
Google Scholar
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Baillargeon J, Polychronopoulou E, Kuo YF, Raji MA. The Impact of substance use disorder on COVID-19 outcomes. Psychiatr Serv. 2021;72(5):578–81.
Article
PubMed
Google Scholar
Velásquez García HA, Wilton J, Smolina K, Chong M, Rasali D, Otterstatter M, et al. Mental health and substance use associated with hospitalization among people with COVID-19: a population-based cohort study. Viruses. 2021;13(11):2196.
Article
PubMed
PubMed Central
Google Scholar
Vallecillo G, Perelló R, Güerri R, Fonseca F, Torrens M. Clinical impact of COVID-19 on people with substance use disorders. J Public Health. 2021;43(1):9–12.
Article
CAS
Google Scholar
Allen B, El Shahawy O, Rogers ES, Hochman S, Khan MR, Krawczyk N. Association of substance use disorders and drug overdose with adverse COVID-19 outcomes in New York city: january-october 2020. J Public Health (Oxf). 2021;43(3):462–5.
Article
PubMed
Google Scholar
Qeadan F, Tingey B, Bern R, Porucznik CA, English K, Saeed AI, et al. Opioid use disorder and health service utilization among COVID-19 patients in the US: a nationwide cohort from the cerner real-world data. EClinicalMedicine. 2021;37: 100938.
Article
PubMed
PubMed Central
Google Scholar
Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry. 2021;26(1):30–9.
Article
CAS
PubMed
Google Scholar
Jamali Z, Emamian MH, Hashemi H, Fotouh A. The association of opioid use disorder and COVID-19 in shahroud Iran. medrxiv. 2021;02(19):21252093.
Google Scholar
Riahi T, Sadeghzadeh-Bazargan A, Shokri S, Ahmadvand D, Hassanlouei B, Baghestani A, et al. The effect of opium on severity of COVID-19 infection: an original study from Iran. Med J Islam Repub Iran. 2021;35:115.
PubMed
PubMed Central
Google Scholar
Joseph DPR, Krovvidi H. Non-respiratory functions of the lung. Contin Educ Anaesth Crit Care Pain. 2013;13(3):98–102.
Article
Google Scholar
Eisenstein TK. The role of opioid receptors in immune system function. Front Immunol. 2019;10:2904.
Article
CAS
PubMed
PubMed Central
Google Scholar
Plein LM, Rittner HL. Opioids and the immune system—friend or foe. Br J Pharmacol. 2018;175(14):2717–25.
Article
CAS
PubMed
Google Scholar
Farhoudian A, Baldacchino A, Clark N, Gerra G, Ekhtiari H, Dom G, et al. COVID-19 and substance use disorders: recommendations to a comprehensive healthcare response an international society of addiction medicine practice and policy interest group position paper. Basic Clin Neurosci. 2020;11(2):133–50.
CAS
PubMed
PubMed Central
Google Scholar
Saeedi M, Omrani-Nava V, Maleki I, Hedayatizadeh-Omran A, Ahmadi A, Moosazadeh M, et al. Opium addiction and COVID-19: truth or false beliefs. Iran J Psychiatry Behav Sci. 2020;14(2):103509.
Article
Google Scholar
Volkow ND. Collision of the COVID-19 and addiction epidemics. Ann Intern Med. 2020;173(1):61–2.
Article
PubMed
Google Scholar
Melamed OC, Hauck TS, Buckley L, Selby P, Mulsant BH. COVID-19 and persons with substance use disorders: Inequities and mitigation strategies. Subst abuse. 2020;41(3):286–91.
Article
Google Scholar
de Bernardis E, Busà L. A putative role for the tobacco mosaic virus in smokers’ resistance to COVID-19. Med Hypotheses. 2020;143: 110153.
Article
PubMed
PubMed Central
Google Scholar
Mhatre S, Srivastava T, Naik S, Patravale V. Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: a review. Phytomed Int J Phytother Phytopharmacol. 2021;85: 153286.
CAS
Google Scholar
Enns A, Pinto A, Venugopal J, Grywacheski V, Gheorghe M, Kakkar T, et al. Substance use and related harms in the context of COVID-19: a conceptual model. Health Promot Chron Dis Prevention Canada Res Policy Pract. 2020;40(11–12):342–9.
Google Scholar
Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(2):e16–25.
Article
CAS
PubMed
PubMed Central
Google Scholar
Namba RS, Singh A, Paxton EW, Inacio MCS. Patient factors associated with prolonged postoperative opioid use after total knee arthroplasty. J Arthroplasty. 2018;33(8):2449–54.
Article
PubMed
Google Scholar
Kobus AM, Smith DH, Morasco BJ, Johnson ES, Yang X, Petrik AF, et al. Correlates of higher-dose opioid medication use for low back pain in primary care. J Pain. 2012;13(11):1131–8.
Article
PubMed
PubMed Central
Google Scholar
Buckeridge D, Huang A, Hanley J, Kelome A, Reidel K, Verma A, et al. Risk of injury associated with opioid use in older adults. J Am Geriatr Soc. 2010;58(9):1664–70.
Article
PubMed
Google Scholar
Ataei M, Shirazi FM, Lamarine RJ, Nakhaee S, Mehrpour O. A double-edged sword of using opioids and COVID-19: a toxicological view. Subst Abuse Treat Prev Policy. 2020;15(1):91.
Article
PubMed
PubMed Central
Google Scholar
Porubsky S, Kuppe C, Maier T, Birk HW, Wörnle M, Moeller MJ, et al. Renal lipidosis in patients enrolled in a methadone substitution program. Arch Pathol Lab Med. 2014;138(5):689–93.
Article
PubMed
Google Scholar
Yamanaka T, Sadikot RT. Opioid effect on lungs. Respirology. 2013;18(2):255–62.
Article
PubMed
Google Scholar
Roy S, Ninkovic J, Banerjee S, Charboneau RG, Das S, Dutta R, et al. Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol. 2011;6(4):442–65.
Article
Google Scholar
García-Albéniz X, del Amo J, Polo R, Morales-Asencio JM, Hernán MA. Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19. Eur J Epidemiol. 2022;37(8):789–96.
Article
PubMed
PubMed Central
Google Scholar
Ayerbe L, Risco-Risco C, Forgnone I, Pérez-Piñar M, Ayis S. Azithromycin in patients with COVID-19: a systematic review and meta-analysis. J Antimicrob Chemother. 2022;77(2):303–9.
Article
CAS
PubMed
Google Scholar
Chang KC, Huang CL, Liang HY, Chang SS, Wang YC, Liang WM, et al. Gender-specific differences in susceptibility to low-dose methadone-associated QTc prolongation in patients with heroin dependence. J Cardiovasc Electrophysiol. 2012;23(5):527–33.
Article
PubMed
Google Scholar
Fonseca F, Marti-Almor J, Pastor A, Cladellas M, Farré M, de la Torre R, et al. Prevalence of long QTc interval in methadone maintenance patients. Drug Alcohol Depend. 2009;99(1–3):327–32.
Article
PubMed
Google Scholar
Kim L, Garg S, O’Halloran A, Whitaker M, Pham H, Anderson EJ, et al. Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US coronavirus Disease 2019 (COVID-19)-associated hospitalization surveillance network (COVID-NET). Clin Infect Dis Off publ Infect Dis Soc Am. 2021;72(9):e206–14.
Article
CAS
Google Scholar
Petrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell L, Chernyak Y, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York city: prospective cohort study. BMJ. 2020;369: m1966.
Article
PubMed
PubMed Central
Google Scholar
Reilev M, Kristensen KB, Pottegård A, Lund LC, Hallas J, Ernst MT, et al. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. Int J Epidemiol. 2020;49(5):1468–81.
Article
PubMed
PubMed Central
Google Scholar
Balaram K, Marwaha R, Kaelber DC. The effects of substance use on severe acute respiratory syndrome coronavirus infection risks and outcomes. Curr Opin Psychiatry. 2021;34(4):386–92.
Article
PubMed
PubMed Central
Google Scholar
Schwetz TA, Calder T, Rosenthal E, Kattakuzhy S, Fauci AS. Opioids and infectious diseases: a converging public health crisis. J Infect Dis. 2019;220(3):346–9.
Article
PubMed
PubMed Central
Google Scholar
Thompson MG, Stenehjem E, Grannis S, Ball SW, Naleway AL, Ong TC, et al. Effectiveness of covid-19 vaccines in ambulatory and inpatient care settings. N Engl J Med. 2021;385(15):1355–71.
Article
CAS
PubMed
Google Scholar
Tenforde MW, Self WH, Adams K, Gaglani M, Ginde AA, McNeal T, et al. Association between mRNA vaccination and COVID-19 hospitalization and disease severity. JAMA. 2021;326(20):2043–54.
Article
CAS
PubMed
Google Scholar
Rzymski P, Kasianchuk N, Sikora D, Poniedziałek B. COVID-19 vaccinations and rates of infections, hospitalizations, ICU admissions, and deaths in Europe during SARS-CoV-2 Omicron wave in the first quarter of 2022. J Med Virol. 2022. https://doi.org/10.1002/jmv.28131.
Article
PubMed
PubMed Central
Google Scholar
Vallecillo G, Durán X, Canosa I, Roquer A, Martinez MC, Perelló R. COVID-19 vaccination coverage and vaccine hesitancy among people with opioid use disorder in Barcelona. Spain Drug Alcohol Rev. 2022;41(6):1311–8.
Article
PubMed
Google Scholar